| Date Filed | Type | Description |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Bowden Christopher (Director) has filed a Form 4 on MIRAGEN THERAPEUTICS, INC.|
Txns:
| Granted 24,000 options to buy
@ $0.6261, valued at
$15k
|
|
| 05/21/2020 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 3,583 shares
@ $50.014, valued at
$179.2k
Exercised 3,583 options to buy
@ $35.16, valued at
$126k
|
|
| 04/15/2020 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,368 shares
@ $40.64, valued at
$96.2k
Exercised 5,280 options to buy
@ $0 |
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 14,191 shares
@ $50.0291, valued at
$710k
Sold 35,447 shares
@ $50.1037, valued at
$1.8M
Exercised 8,526 options to buy
@ $35.16, valued at
$299.8k
Exercised 35,447 options to buy
@ $35.16, valued at
$1.2M
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
3
| Bowden Christopher (Director) has filed a Form 3 on ZIOPHARM ONCOLOGY INC |
| 06/21/2019 |
4
| Bowden Christopher (Director) has filed a Form 4 on MIRAGEN THERAPEUTICS, INC.|
Txns:
| Granted 12,000 options to buy
@ $2.36, valued at
$28.3k
|
|
| 04/03/2019 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 5,854 shares
@ $66.03, valued at
$386.5k
Sold 2,546 shares
@ $66.85, valued at
$170.2k
Sold 1,500 shares
@ $68.09, valued at
$102.1k
Sold 100 shares
@ $68.72, valued at
$6.9k
Exercised 10,000 options to buy
@ $35.16, valued at
$351.6k
|
|
| 03/19/2019 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 8,700 shares
@ $64.09, valued at
$557.6k
Sold 1,300 shares
@ $64.64, valued at
$84k
Exercised 10,000 options to buy
@ $35.16, valued at
$351.6k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,960 shares
@ $52.82, valued at
$103.5k
Exercised 6,265 options to buy
@ $0 |
|
| 08/31/2018 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 300 shares
@ $80, valued at
$24k
Sold 1,700 shares
@ $80.03, valued at
$136.1k
Exercised 300 options to buy
@ $35.16, valued at
$10.5k
Exercised 1,700 options to buy
@ $35.16, valued at
$59.8k
|
|
| 07/24/2018 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 6,265 options to buy
@ $0 |
|
| 07/12/2018 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 1,200 shares
@ $86.42, valued at
$103.7k
Sold 800 shares
@ $87.26, valued at
$69.8k
Exercised 2,000 options to buy
@ $35.16, valued at
$70.3k
|
|
| 06/28/2018 |
4
| Bowden Christopher (Director) has filed a Form 4 on MIRAGEN THERAPEUTICS, INC.|
Txns:
| Granted 12,000 options to buy
@ $6.46, valued at
$77.5k
|
|
| 06/14/2018 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 1,800 shares
@ $92.84, valued at
$167.1k
Sold 200 shares
@ $93.37, valued at
$18.7k
Exercised 2,000 options to buy
@ $35.16, valued at
$70.3k
|
|
| 05/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2018 |
4
| Bowden Christopher (Chief Medical Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $81.38, valued at
$162.8k
Exercised 2,000 options to buy
@ $35.16, valued at
$70.3k
|
|
|